587 related articles for article (PubMed ID: 19486163)
21. Oropharyngeal carriage of macrolide-resistant viridans group streptococci: a prevalence study among healthy adults in Belgium.
Malhotra-Kumar S; Lammens C; Martel A; Mallentjer C; Chapelle S; Verhoeven J; Wijdooghe M; Haesebrouck F; Goossens H
J Antimicrob Chemother; 2004 Feb; 53(2):271-6. PubMed ID: 14729750
[TBL] [Abstract][Full Text] [Related]
22. Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.
Reig M; Galan J; Baquero F; Perez-Diaz JC
Antimicrob Agents Chemother; 2001 Feb; 45(2):630-2. PubMed ID: 11158770
[TBL] [Abstract][Full Text] [Related]
23. A study on erm(B)-mediated MLS resistance in Streptococcus pyogenes clinical isolates.
Rombini S; Petrelli D; Bolli E; Tran CN; Falconi M; Di Luca MC; Prenna M; Ripa S; Vitali LA
Diagn Microbiol Infect Dis; 2011 Jul; 70(3):387-94. PubMed ID: 21683270
[TBL] [Abstract][Full Text] [Related]
24. Multicentre surveillance of the prevalence and molecular epidemiology of macrolide resistance among pharyngeal isolates of group A streptococci in the USA.
Green MD; Beall B; Marcon MJ; Allen CH; Bradley JS; Dashefsky B; Gilsdorf JR; Schutze GE; Smith C; Walter EB; Martin JM; Edwards KM; Barbadora KA; Wald ER
J Antimicrob Chemother; 2006 Jun; 57(6):1240-3. PubMed ID: 16556634
[TBL] [Abstract][Full Text] [Related]
25. A family outbreak due to an emm-type 11 multiresistant strain of Streptococcus pyogenes.
Martinaud C; Doloy A; Graffin B; Gaillard T; Poyet R; Mallet S; Carsuzaa F; Brisou P; Bouvet A
Clin Microbiol Infect; 2010 Mar; 16(3):292-5. PubMed ID: 19519845
[TBL] [Abstract][Full Text] [Related]
26. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
[TBL] [Abstract][Full Text] [Related]
27. Emergence of high-level fluoroquinolone resistance in emm6 Streptococcus pyogenes and in vitro resistance selection with ciprofloxacin, levofloxacin and moxifloxacin.
Malhotra-Kumar S; Van Heirstraeten L; Lammens C; Chapelle S; Goossens H
J Antimicrob Chemother; 2009 May; 63(5):886-94. PubMed ID: 19279051
[TBL] [Abstract][Full Text] [Related]
28. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
[TBL] [Abstract][Full Text] [Related]
29. [Resistance to macrolides in the species Streptococcus pyogenes in the Czech Republic in 1996-2003].
Urbásková P; Jakubů V;
Epidemiol Mikrobiol Imunol; 2004 Nov; 53(4):196-202. PubMed ID: 15633541
[TBL] [Abstract][Full Text] [Related]
30. Susceptibility of Streptococcus pyogenes to two macrolides in northern Israel.
Sakran W; Raz R; Chazan B; Koren A; Colodner R
Int J Antimicrob Agents; 2004 May; 23(5):517-9. PubMed ID: 15120735
[TBL] [Abstract][Full Text] [Related]
31. Clonal relationships among isolates of erythromycin-resistant Streptococcus pyogenes of different geographical origin.
Kataja J; Huovinen P; Efstratiou A; Pérez-Trallero E; Seppälä H;
Eur J Clin Microbiol Infect Dis; 2002 Aug; 21(8):589-95. PubMed ID: 12226689
[TBL] [Abstract][Full Text] [Related]
32. Macrolide-resistant Streptococcus pyogenes in Central Greece: prevalence; mechanism and molecular identification.
Malli E; Tatsidou E; Damani A; Pantelidi K; Petinaki E; Skoulakis C; Drougka E; Spiliopoulou I
Int J Antimicrob Agents; 2010 Jun; 35(6):614-5. PubMed ID: 20206477
[No Abstract] [Full Text] [Related]
33. Characterisation of the main clones of Streptococcus pyogenes carrying the ermA (subclass TR) gene in Spain.
Montes M; Orden B; Tamayo E; Alos JI; Pérez-Trallero E
Int J Antimicrob Agents; 2006 Nov; 28(5):408-12. PubMed ID: 17000084
[TBL] [Abstract][Full Text] [Related]
34. Illustration of a common framework for relating multiple typing methods by application to macrolide-resistant Streptococcus pyogenes.
Carriço JA; Silva-Costa C; Melo-Cristino J; Pinto FR; de Lencastre H; Almeida JS; Ramirez M
J Clin Microbiol; 2006 Jul; 44(7):2524-32. PubMed ID: 16825375
[TBL] [Abstract][Full Text] [Related]
35. Association of group A streptococcal emm types with virulence traits and macrolide-resistance genes is independent of the source of isolation.
Creti R; Gherardi G; Imperi M; von Hunolstein C; Baldassarri L; Pataracchia M; Alfarone G; Cardona F; Dicuonzo G; Orefici G
J Med Microbiol; 2005 Oct; 54(Pt 10):913-917. PubMed ID: 16157543
[TBL] [Abstract][Full Text] [Related]
36. Macrolide-resistance genes in clinical isolates of Streptococcus pyogenes.
Cascone C; Santagati M; Noviello S; Iannelli F; Esposito S; Pozzi G; Stefani S
Microb Drug Resist; 2002; 8(2):129-32. PubMed ID: 12118517
[TBL] [Abstract][Full Text] [Related]
37. Molecular characterization of erythromycin-resistant Streptococcus agalactiae strains.
Domelier AS; van der Mee-Marquet N; Arnault L; Mereghetti L; Lanotte P; Rosenau A; Lartigue MF; Quentin R
J Antimicrob Chemother; 2008 Dec; 62(6):1227-33. PubMed ID: 18786936
[TBL] [Abstract][Full Text] [Related]
38. A new phenotype of resistance to lincosamide and streptogramin A-type antibiotics in Streptococcus agalactiae in New Zealand.
Malbruny B; Werno AM; Anderson TP; Murdoch DR; Leclercq R
J Antimicrob Chemother; 2004 Dec; 54(6):1040-4. PubMed ID: 15537693
[TBL] [Abstract][Full Text] [Related]
39. Epidemiological characterization of Streptococcus pyogenes isolated from patients with multiple onsets of pharyngitis.
Ogawa T; Terao Y; Sakata H; Okuni H; Ninomiya K; Ikebe K; Maeda Y; Kawabata S
FEMS Microbiol Lett; 2011 May; 318(2):143-51. PubMed ID: 21362024
[TBL] [Abstract][Full Text] [Related]
40. Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel.
Nir-Paz R; Block C; Shasha D; Korenman Z; Gorodnitzky Z; Jaffe J; Ron M; Michael-Gayego A; Cohen-Poradosu R; Shapiro M; Moses AE
Int J Antimicrob Agents; 2006 Oct; 28(4):313-9. PubMed ID: 16973336
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]